Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to 235.52%.

  • Metagenomi's EBITDA Margin fell 890200.0% to 235.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 291.16%, marking a year-over-year decrease of 1605200.0%. This contributed to the annual value of 147.72% for FY2024, which is 43900.0% up from last year.
  • Per Metagenomi's latest filing, its EBITDA Margin stood at 235.52% for Q3 2025, which was down 890200.0% from 236.78% recorded in Q2 2025.
  • In the past 5 years, Metagenomi's EBITDA Margin ranged from a high of 53.61% in Q2 2024 and a low of 608.84% during Q1 2025
  • For the 3-year period, Metagenomi's EBITDA Margin averaged around 216.09%, with its median value being 186.12% (2023).
  • In the last 5 years, Metagenomi's EBITDA Margin soared by 626800bps in 2024 and then crashed by -3818600bps in 2025.
  • Over the past 3 years, Metagenomi's EBITDA Margin (Quarter) stood at 153.5% in 2023, then plummeted by -65bps to 253.05% in 2024, then increased by 7bps to 235.52% in 2025.
  • Its EBITDA Margin was 235.52% in Q3 2025, compared to 236.78% in Q2 2025 and 608.84% in Q1 2025.